%0 Journal Article
%T Impact of novel N
%A Jabed Akhtar
%A Jagdeep Kaur
%A K Gopinath Achary
%A Ranbir Chander Sobti
%A Sajad Shahbazi
%A Sameena Wani
%A Shikha Singh
%A Sobhagyalaxmi Jema
%J Innate Immunity
%@ 1753-4267
%D 2018
%R 10.1177/1753425917740727
%X NO donor drugs showed a significant therapeutic effect in the treatment of many diseases, such as arteriopathies, various acute and chronic inflammatory conditions, and several degenerative diseases. NO-releasing anti-inflammatory drugs are the prototypes of a novel class of compounds, combining the pharmacological activities of anti-inflammatory and anti-nociceptive of drugs with those of NO, thus possessing potential therapeutic applications in a great variety of diseases. In this study, we designed and predicted biological activity by targeting cyclooxygenase type 2 (COX-2) and NF-¦ÊB subunits and pharmacological profiling along with toxicity predictions of various N-aryl piperamides linked via an ester bond to a spacer that is bound to a NO-releasing moiety (-ONO2). The result of absorption, distribution, metabolism and excretion and Docking studies indicated that among 51 designed molecules PA-3¡äK showed the best binding potential in both the substrate and inhibitory binding pocket of the COX-2 enzyme with affinity values of ¨C9.33 and ¨C5.12 for PDB ID 1CVU and 3LN1, respectively, thereby having the potential to be developed as a therapeutic agent. The results of cell viabilities indicated that PA-3¡äk possesses the best cell viability property with respect to its dose (17.33£¿ng/ml), with 67.76% and 67.93% viable cells for CHME3 and SVG cell lines, respectively
%K Nitric oxide
%K Alzheimer¡¯s disease
%K N-aryl piperamides
%K cyclooxygenase type 2
%K ADMET
%K docking
%U https://journals.sagepub.com/doi/full/10.1177/1753425917740727